The global narcolepsy market is primarily being driven by the high incidence of narcolepsy, growing awareness about the disorder, and rising demand for treating narcolepsy, finds a report by Transparency Market Research.
Statistics show that there are over 3 million people suffering from narcolepsy all over the world, which makes the disorder as common as multiple sclerosis and Parkinson’s disease and more common than cystic fibrosis, according to “Narcolepsy Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.” Introduction of innovative drugs to treat the disorder and other treatment options is also fueling the growth of this market.
Currently, North America holds the largest share in the global narcolepsy market, which is closely followed by Europe. The report attributes this to “the growing number of cases of narcolepsy in the region.” However, analysts predict that Asia Pacific will show the fastest growth rate in this market in the coming years due to the increasing number of treatment options and increasing purchasing power of patients.
